Switching from Aflibercept to Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration: Short-Term Results from Real-Life Study.

Saved in:
Bibliographic Details
Title: Switching from Aflibercept to Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration: Short-Term Results from Real-Life Study.
Authors: Kucharczuk, Jan1 (AUTHOR), Kasprzak, Hubert1,2 (AUTHOR), Gawęcki, Maciej1,2 (AUTHOR) maciej@gawecki.com
Source: Journal of Clinical Medicine. Oct2025, Vol. 14 Issue 20, p7345. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20770383
DOI:10.3390/jcm14207345